Cancer Control and Survivorship
Numerous clinical trials are always active (ie, open and enrolling patients) in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults who have or are at risk of developing cancer. The buttons below depict the general research categories being investigated in ECOG-ACRIN clinical trials. To access information within a particular category, click on the relevant button. Upon clicking, the color of the button will change from grey to red, and a table will appear on screen. The table will display the study number, study description, lead investigator(s), accrual goal, and the date participating institutions started to open the trial. Please read the ECOG-ACRIN Disclaimer in its entirety before accessing this information.
Need More Information About a Particular Clinical Trial? Contact Us
To view educational materials, click on the links provided in the Educational Materials column. To send an email to the study chair, click on their name and a new email window will open.
Trials Currently Recruiting Participants - Cancer Control and Survivorship Committee
| STUDY | DESCRIPTION | ECOG-ACRIN POS CHAIR (STATISTICIAN) | ACCRUAL GOAL | DATE ACTIVATED | EDUCATIONAL MATERIALS |
|---|---|---|---|---|---|
| EAQ172 | Optimizing Immunosuppression for Steroid-Refractory Anti-PD-1/PD-L1 Pneumonitis | Jarushka Naidoo, MB, BCH, Chair Sheetal M. Kircher, MD, Co-Chair (Ju-Whei Lee, PhD) | 36 | 06/25/2020 | EAQ172 Resources |
| EAQ191/ CARISMA | Cancer Therapy Risk Reduction with Intensive Systolic BP Managemet (CARISMA) - A Phase II Study | Bonnie Ky, MD, Chair Kenneth Margulies, MD, Co-Chair (Tao Liu, PhD and JoRean D. Sicks, PhD) | 60 | 09/10/2020 | EAQ191 Resources |
Download 
© 2012-2020 ECOG-ACRIN Cancer Research Group. All rights reserved. | Disclaimer